Global Neurological Biomarker Sales Market Report 2016

October 2016 | 117 pages | ID: G236A1CA155EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Neurological Biomarker

Revenue, means the sales value of Neurological Biomarker

This report studies sales (consumption) of Neurological Biomarker in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

• Myriad RBM
• Proteome Sciences
• QIAGEN
• Thermo Fisher Scientific
• AbaStar MDx
• Abiant
• Acumen Pharmaceuticals
• Aepodia
• Alseres Pharmaceuticals
• Athena Diagnostics
• Banyan Biomarkers
• Cisbio Bioassays
• Diagenic
• Proteosys
• Psynova Neurotech

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Neurological Biomarker in these regions, from 2011 to 2021 (forecast), like

• United States
• China
• Europe
• Japan

Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Neurological Biomarker in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

Global Neurological Biomarker Sales Market Report 2016

1 NEUROLOGICAL BIOMARKER OVERVIEW

1.1 Product Overview and Scope of Neurological Biomarker
1.2 Classification of Neurological Biomarker
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Neurological Biomarker
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 Neurological Biomarker Market by Regions
  1.4.1 United States Status and Prospect (2011-2021)
  1.4.2 China Status and Prospect (2011-2021)
  1.4.3 Europe Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Neurological Biomarker (2011-2021)
  1.5.1 Global Neurological Biomarker Sales and Growth Rate (2011-2021)
  1.5.2 Global Neurological Biomarker Revenue and Growth Rate (2011-2021)

2 GLOBAL NEUROLOGICAL BIOMARKER COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Global Neurological Biomarker Market Competition by Manufacturers
  2.1.1 Global Neurological Biomarker Sales and Market Share of Key Manufacturers (2011-2016)
  2.1.2 Global Neurological Biomarker Revenue and Share by Manufacturers (2011-2016)
2.2 Global Neurological Biomarker (Volume and Value) by Type
  2.2.1 Global Neurological Biomarker Sales and Market Share by Type (2011-2016)
  2.2.2 Global Neurological Biomarker Revenue and Market Share by Type (2011-2016)
2.3 Global Neurological Biomarker (Volume and Value) by Regions
  2.3.1 Global Neurological Biomarker Sales and Market Share by Regions (2011-2016)
  2.3.2 Global Neurological Biomarker Revenue and Market Share by Regions (2011-2016)
2.4 Global Neurological Biomarker (Volume) by Application

3 UNITED STATES NEUROLOGICAL BIOMARKER (VOLUME, VALUE AND SALES PRICE)

3.1 United States Neurological Biomarker Sales and Value (2011-2016)
  3.1.1 United States Neurological Biomarker Sales and Growth Rate (2011-2016)
  3.1.2 United States Neurological Biomarker Revenue and Growth Rate (2011-2016)
  3.1.3 United States Neurological Biomarker Sales Price Trend (2011-2016)
3.2 United States Neurological Biomarker Sales and Market Share by Manufacturers
3.3 United States Neurological Biomarker Sales and Market Share by Type
3.4 United States Neurological Biomarker Sales and Market Share by Application

4 CHINA NEUROLOGICAL BIOMARKER (VOLUME, VALUE AND SALES PRICE)

4.1 China Neurological Biomarker Sales and Value (2011-2016)
  4.1.1 China Neurological Biomarker Sales and Growth Rate (2011-2016)
  4.1.2 China Neurological Biomarker Revenue and Growth Rate (2011-2016)
  4.1.3 China Neurological Biomarker Sales Price Trend (2011-2016)
4.2 China Neurological Biomarker Sales and Market Share by Manufacturers
4.3 China Neurological Biomarker Sales and Market Share by Type
4.4 China Neurological Biomarker Sales and Market Share by Application

5 EUROPE NEUROLOGICAL BIOMARKER (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Neurological Biomarker Sales and Value (2011-2016)
  5.1.1 Europe Neurological Biomarker Sales and Growth Rate (2011-2016)
  5.1.2 Europe Neurological Biomarker Revenue and Growth Rate (2011-2016)
  5.1.3 Europe Neurological Biomarker Sales Price Trend (2011-2016)
5.2 Europe Neurological Biomarker Sales and Market Share by Manufacturers
5.3 Europe Neurological Biomarker Sales and Market Share by Type
5.4 Europe Neurological Biomarker Sales and Market Share by Application

6 JAPAN NEUROLOGICAL BIOMARKER (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Neurological Biomarker Sales and Value (2011-2016)
  6.1.1 Japan Neurological Biomarker Sales and Growth Rate (2011-2016)
  6.1.2 Japan Neurological Biomarker Revenue and Growth Rate (2011-2016)
  6.1.3 Japan Neurological Biomarker Sales Price Trend (2011-2016)
6.2 Japan Neurological Biomarker Sales and Market Share by Manufacturers
6.3 Japan Neurological Biomarker Sales and Market Share by Type
6.4 Japan Neurological Biomarker Sales and Market Share by Application

7 GLOBAL NEUROLOGICAL BIOMARKER MANUFACTURERS ANALYSIS

7.1 Myriad RBM
  7.1.1 Company Basic Information, Manufacturing Base and Competitors
  7.1.2 Neurological Biomarker Product Type, Application and Specification
    7.1.2.1 Type I
    7.1.2.2 Type II
  7.1.3 Myriad RBM Neurological Biomarker Sales, Revenue, Price and Gross Margin (2011-2016)
  7.1.4 Main Business/Business Overview
7.2 Proteome Sciences
  7.2.1 Company Basic Information, Manufacturing Base and Competitors
  7.2.2 117 Product Type, Application and Specification
    7.2.2.1 Type I
    7.2.2.2 Type II
  7.2.3 Proteome Sciences Neurological Biomarker Sales, Revenue, Price and Gross Margin (2011-2016)
  7.2.4 Main Business/Business Overview
7.3 QIAGEN
  7.3.1 Company Basic Information, Manufacturing Base and Competitors
  7.3.2 134 Product Type, Application and Specification
    7.3.2.1 Type I
    7.3.2.2 Type II
  7.3.3 QIAGEN Neurological Biomarker Sales, Revenue, Price and Gross Margin (2011-2016)
  7.3.4 Main Business/Business Overview
7.4 Thermo Fisher Scientific
  7.4.1 Company Basic Information, Manufacturing Base and Competitors
  7.4.2 Oct Product Type, Application and Specification
    7.4.2.1 Type I
    7.4.2.2 Type II
  7.4.3 Thermo Fisher Scientific Neurological Biomarker Sales, Revenue, Price and Gross Margin (2011-2016)
  7.4.4 Main Business/Business Overview
7.5 AbaStar MDx
  7.5.1 Company Basic Information, Manufacturing Base and Competitors
  7.5.2 Product Type, Application and Specification
    7.5.2.1 Type I
    7.5.2.2 Type II
  7.5.3 AbaStar MDx Neurological Biomarker Sales, Revenue, Price and Gross Margin (2011-2016)
  7.5.4 Main Business/Business Overview
7.6 Abiant
  7.6.1 Company Basic Information, Manufacturing Base and Competitors
  7.6.2 Million USD Product Type, Application and Specification
    7.6.2.1 Type I
    7.6.2.2 Type II
  7.6.3 Abiant Neurological Biomarker Sales, Revenue, Price and Gross Margin (2011-2016)
  7.6.4 Main Business/Business Overview
7.7 Acumen Pharmaceuticals
  7.7.1 Company Basic Information, Manufacturing Base and Competitors
  7.7.2 Pharma & Healthcare Product Type, Application and Specification
    7.7.2.1 Type I
    7.7.2.2 Type II
  7.7.3 Acumen Pharmaceuticals Neurological Biomarker Sales, Revenue, Price and Gross Margin (2011-2016)
  7.7.4 Main Business/Business Overview
7.8 Aepodia
  7.8.1 Company Basic Information, Manufacturing Base and Competitors
  7.8.2 Product Type, Application and Specification
    7.8.2.1 Type I
    7.8.2.2 Type II
  7.8.3 Aepodia Neurological Biomarker Sales, Revenue, Price and Gross Margin (2011-2016)
  7.8.4 Main Business/Business Overview
7.9 Alseres Pharmaceuticals
  7.9.1 Company Basic Information, Manufacturing Base and Competitors
  7.9.2 Product Type, Application and Specification
    7.9.2.1 Type I
    7.9.2.2 Type II
  7.9.3 Alseres Pharmaceuticals Neurological Biomarker Sales, Revenue, Price and Gross Margin (2011-2016)
  7.9.4 Main Business/Business Overview
7.10 Athena Diagnostics
  7.10.1 Company Basic Information, Manufacturing Base and Competitors
  7.10.2 Product Type, Application and Specification
    7.10.2.1 Type I
    7.10.2.2 Type II
  7.10.3 Athena Diagnostics Neurological Biomarker Sales, Revenue, Price and Gross Margin (2011-2016)
  7.10.4 Main Business/Business Overview
7.11 Banyan Biomarkers
7.12 Cisbio Bioassays
7.13 Diagenic
7.14 Proteosys
7.15 Psynova Neurotech

8 NEUROLOGICAL BIOMARKER MAUFACTURING COST ANALYSIS

8.1 Neurological Biomarker Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Process Analysis of Neurological Biomarker

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Neurological Biomarker Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Neurological Biomarker Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL NEUROLOGICAL BIOMARKER MARKET FORECAST (2016-2021)

12.1 Global Neurological Biomarker Sales, Revenue Forecast (2016-2021)
12.2 Global Neurological Biomarker Sales Forecast by Regions (2016-2021)
12.3 Global Neurological Biomarker Sales Forecast by Type (2016-2021)
12.4 Global Neurological Biomarker Sales Forecast by Application (2016-2021)

13 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Neurological Biomarker
Table Classification of Neurological Biomarker
Figure Global Sales Market Share of Neurological Biomarker by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Applications of Neurological Biomarker
Figure Global Sales Market Share of Neurological Biomarker by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure United States Neurological Biomarker Revenue and Growth Rate (2011-2021)
Figure China Neurological Biomarker Revenue and Growth Rate (2011-2021)
Figure Europe Neurological Biomarker Revenue and Growth Rate (2011-2021)
Figure Japan Neurological Biomarker Revenue and Growth Rate (2011-2021)
Figure Global Neurological Biomarker Sales and Growth Rate (2011-2021)
Figure Global Neurological Biomarker Revenue and Growth Rate (2011-2021)
Table Global Neurological Biomarker Sales of Key Manufacturers (2011-2016)
Table Global Neurological Biomarker Sales Share by Manufacturers (2011-2016)
Figure 2015 Neurological Biomarker Sales Share by Manufacturers
Figure 2016 Neurological Biomarker Sales Share by Manufacturers
Table Global Neurological Biomarker Revenue by Manufacturers (2011-2016)
Table Global Neurological Biomarker Revenue Share by Manufacturers (2011-2016)
Table 2015 Global Neurological Biomarker Revenue Share by Manufacturers
Table 2016 Global Neurological Biomarker Revenue Share by Manufacturers
Table Global Neurological Biomarker Sales and Market Share by Type (2011-2016)
Table Global Neurological Biomarker Sales Share by Type (2011-2016)
Figure Sales Market Share of Neurological Biomarker by Type (2011-2016)
Figure Global Neurological Biomarker Sales Growth Rate by Type (2011-2016)
Table Global Neurological Biomarker Revenue and Market Share by Type (2011-2016)
Table Global Neurological Biomarker Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Neurological Biomarker by Type (2011-2016)
Figure Global Neurological Biomarker Revenue Growth Rate by Type (2011-2016)
Table Global Neurological Biomarker Sales and Market Share by Regions (2011-2016)
Table Global Neurological Biomarker Sales Share by Regions (2011-2016)
Figure Sales Market Share of Neurological Biomarker by Regions (2011-2016)
Figure Global Neurological Biomarker Sales Growth Rate by Regions (2011-2016)
Table Global Neurological Biomarker Revenue and Market Share by Regions (2011-2016)
Table Global Neurological Biomarker Revenue Share by Regions (2011-2016)
Figure Revenue Market Share of Neurological Biomarker by Regions (2011-2016)
Figure Global Neurological Biomarker Revenue Growth Rate by Regions (2011-2016)
Table Global Neurological Biomarker Sales and Market Share by Application (2011-2016)
Table Global Neurological Biomarker Sales Share by Application (2011-2016)
Figure Sales Market Share of Neurological Biomarker by Application (2011-2016)
Figure Global Neurological Biomarker Sales Growth Rate by Application (2011-2016)
Figure United States Neurological Biomarker Sales and Growth Rate (2011-2016)
Figure United States Neurological Biomarker Revenue and Growth Rate (2011-2016)
Figure United States Neurological Biomarker Sales Price Trend (2011-2016)
Table United States Neurological Biomarker Sales by Manufacturers (2011-2016)
Table United States Neurological Biomarker Market Share by Manufacturers (2011-2016)
Table United States Neurological Biomarker Sales by Type (2011-2016)
Table United States Neurological Biomarker Market Share by Type (2011-2016)
Table United States Neurological Biomarker Sales by Application (2011-2016)
Table United States Neurological Biomarker Market Share by Application (2011-2016)
Figure China Neurological Biomarker Sales and Growth Rate (2011-2016)
Figure China Neurological Biomarker Revenue and Growth Rate (2011-2016)
Figure China Neurological Biomarker Sales Price Trend (2011-2016)
Table China Neurological Biomarker Sales by Manufacturers (2011-2016)
Table China Neurological Biomarker Market Share by Manufacturers (2011-2016)
Table China Neurological Biomarker Sales by Type (2011-2016)
Table China Neurological Biomarker Market Share by Type (2011-2016)
Table China Neurological Biomarker Sales by Application (2011-2016)
Table China Neurological Biomarker Market Share by Application (2011-2016)
Figure Europe Neurological Biomarker Sales and Growth Rate (2011-2016)
Figure Europe Neurological Biomarker Revenue and Growth Rate (2011-2016)
Figure Europe Neurological Biomarker Sales Price Trend (2011-2016)
Table Europe Neurological Biomarker Sales by Manufacturers (2011-2016)
Table Europe Neurological Biomarker Market Share by Manufacturers (2011-2016)
Table Europe Neurological Biomarker Sales by Type (2011-2016)
Table Europe Neurological Biomarker Market Share by Type (2011-2016)
Table Europe Neurological Biomarker Sales by Application (2011-2016)
Table Europe Neurological Biomarker Market Share by Application (2011-2016)
Figure Japan Neurological Biomarker Sales and Growth Rate (2011-2016)
Figure Japan Neurological Biomarker Revenue and Growth Rate (2011-2016)
Figure Japan Neurological Biomarker Sales Price Trend (2011-2016)
Table Japan Neurological Biomarker Sales by Manufacturers (2011-2016)
Table Japan Neurological Biomarker Market Share by Manufacturers (2011-2016)
Table Japan Neurological Biomarker Sales by Type (2011-2016)
Table Japan Neurological Biomarker Market Share by Type (2011-2016)
Table Japan Neurological Biomarker Sales by Application (2011-2016)
Table Japan Neurological Biomarker Market Share by Application (2011-2016)
Table Myriad RBM Basic Information List
Table Myriad RBM Neurological Biomarker Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Myriad RBM Neurological Biomarker Global Market Share (2011-2016)
Table Proteome Sciences Basic Information List
Table Proteome Sciences Neurological Biomarker Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Proteome Sciences Neurological Biomarker Global Market Share (2011-2016)
Table QIAGEN Basic Information List
Table QIAGEN Neurological Biomarker Sales, Revenue, Price and Gross Margin (2011-2016)
Figure QIAGEN Neurological Biomarker Global Market Share (2011-2016)
Table Thermo Fisher Scientific Basic Information List
Table Thermo Fisher Scientific Neurological Biomarker Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Thermo Fisher Scientific Neurological Biomarker Global Market Share (2011-2016)
Table AbaStar MDx Basic Information List
Table AbaStar MDx Neurological Biomarker Sales, Revenue, Price and Gross Margin (2011-2016)
Figure AbaStar MDx Neurological Biomarker Global Market Share (2011-2016)
Table Abiant Basic Information List
Table Abiant Neurological Biomarker Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Abiant Neurological Biomarker Global Market Share (2011-2016)
Table Acumen Pharmaceuticals Basic Information List
Table Acumen Pharmaceuticals Neurological Biomarker Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Acumen Pharmaceuticals Neurological Biomarker Global Market Share (2011-2016)
Table Aepodia Basic Information List
Table Aepodia Neurological Biomarker Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Aepodia Neurological Biomarker Global Market Share (2011-2016)
Table Alseres Pharmaceuticals Basic Information List
Table Alseres Pharmaceuticals Neurological Biomarker Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Alseres Pharmaceuticals Neurological Biomarker Global Market Share (2011-2016)
Table Athena Diagnostics Basic Information List
Table Athena Diagnostics Neurological Biomarker Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Athena Diagnostics Neurological Biomarker Global Market Share (2011-2016)
Table Banyan Biomarkers Basic Information List
Table Banyan Biomarkers Neurological Biomarker Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Banyan Biomarkers Neurological Biomarker Global Market Share (2011-2016)
Table Cisbio Bioassays Basic Information List
Table Cisbio Bioassays Neurological Biomarker Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Cisbio Bioassays Neurological Biomarker Global Market Share (2011-2016)
Table Diagenic Basic Information List
Table Diagenic Neurological Biomarker Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Diagenic Neurological Biomarker Global Market Share (2011-2016)
Table Proteosys Basic Information List
Table Proteosys Neurological Biomarker Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Proteosys Neurological Biomarker Global Market Share (2011-2016)
Table Psynova Neurotech Basic Information List
Table Psynova Neurotech Neurological Biomarker Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Psynova Neurotech Neurological Biomarker Global Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Neurological Biomarker
Figure Manufacturing Process Analysis of Neurological Biomarker
Figure Neurological Biomarker Industrial Chain Analysis
Table Raw Materials Sources of Neurological Biomarker Major Manufacturers in 2015
Table Major Buyers of Neurological Biomarker
Table Distributors/Traders List
Figure Global Neurological Biomarker Sales and Growth Rate Forecast (2016-2021)
Figure Global Neurological Biomarker Revenue and Growth Rate Forecast (2016-2021)
Table Global Neurological Biomarker Sales Forecast by Regions (2016-2021)
Table Global Neurological Biomarker Sales Forecast by Type (2016-2021)
Table Global Neurological Biomarker Sales Forecast by Application (2016-2021)